Pioglitazone prevented AFib by increased membrane potential through electrophysiological remodeling both reduced angiotensin 2-induced potassium channel remodeling on isolated non-diabetic animal atrial myocytes and attenuation of angiotensin 2-induced L-type calcium channel remodeling [67]. The gene discussed is AGT; the disease is atrial fibrillation.